CCCC - Balance Sheet - C4 Therapeutics, Inc.

Current Liabilities	45.2 M
Accounts Payable	1.33 M
Short-Term Debt	5.77 M
Other Current Liabilities	38.1 M
Non-Current Liabilities	88.4 M
Long-Term Debt	60 M
Other Non-Current Liabilities	28.5 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	55.5	126.6	29.8	76.1	181.7	90.5	36.3
Short Term Investments	189.4	127.1	246.4	233.2	190.0	0	0
Receivables	3.1	11.8	1.5	5.7	4.5	4.6	86.4
Inventory	0	0	(61.0)	0	0	1	1
Other Current Assets	9.8	5.7	9.9	21.4	9.7	3.2	0.8
Total Current Assets	257.8	271.2	287.6	325.7	381.0	96.8	123.5
PP&E	63.4	71.1	77.5	35.1	16.6	18.9	20.4
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	22.4	28.0	61.0	142.2	2.6	2.6	2.6
Other Long Term Assets	6.1	6.2	4.8	3.8	0	0	0
Other Assets	0	0	0	0	0	0	0
Total Assets	349.6	376.5	430.8	506.8	400.1	118.3	146.5
LIABILITIES
Accounts Payable	1.3	1.4	1.2	4.5	5.7	5.4	1.2
Short Term Debt	5.8	5.2	11.7	2.7	2.1	0.9	0.7
Other Current Liabilities	19.4	20.6	15.1	12.3	8.5	27.4	3.0
Total Current Liabilities	45.2	42.8	44.5	51.2	43.9	33.6	23.9
Long Term Debt	60.0	65.8	80.2	72.3	33.7	12.9	13.7
Deferred Tax Income	0	0	9.2	10.8	10.1	0	(13.7)
Other Liabilities	0	0	0	(30.8)	(11.8)	111.0	111.0
Total Liabilities	133.6	130.3	141.6	117.2	119.3	230.2	226.2
EQUITY
Common Stock	7 K	6 K	5 K	5 K	4 K	1 K	1 K
Retained Earnings	(633.7)	(528.4)	(395.9)	(267.7)	(183.8)	(117.5)	(83.4)
Other Accumulative Comprehensive Income/Loss	53 K	(0.1)	(4.1)	(0.8)	13 K	1 K	(2.5)
Total Equity	216.0	246.1	289.2	389.6	280.8	(112.0)	(79.8)
Total Liabilities and Equity	349.6	376.5	430.8	506.8	400.1	118.3	146.5
SHARES OUTSTANDING
Common Shares Outstanding	69.4	49.6	48.9	46.0	43.1	43.0	14.8

Free